R:\regulatory Affairs 2\andas\pimecrolimus Cream 1% (211769)\labeling\jpeg Files\logo.jpg (246b0bfd C404 498d 9608 14a73c4653b0 00)
Pimecrolimus Cream
Product Images NDC 68462-609
7 FDA label images from Glenmark Pharmaceuticals Inc., Usa · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Pimecrolimus (NDC 68462-609). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
R:\regulatory Affairs 2\andas\pimecrolimus Cream 1% (211769)\labeling\jpeg Files\logo.jpg (246b0bfd C404 498d 9608 14a73c4653b0 01)
Z:\regulatory Affairs 2\andas\pimecrolimus Cream 1% (211769)\labeling\jpeg Files\figure 2.jpg (246b0bfd C404 498d 9608 14a73c4653b0 02)
A line graph titled 'Mean Erythema Over Time' showing the mean erythema score with 95% confidence intervals on the y-axis and time in days on the x-axis. The graph compares Pimecrolimus cream, 1% and a vehicle control over a 43-day period. Scores for Pimecrolimus cream decrease over time, while vehicle scores remain relatively constant.*
Z:\regulatory Affairs 2\andas\pimecrolimus Cream 1% (211769)\labeling\jpeg Files\figure 1.jpg (246b0bfd C404 498d 9608 14a73c4653b0 03)
A line graph titled 'Body Surface Area Over Time' comparing the percentage of body surface area affected over a 43-day period. Two data series are shown: one for Pimecrolimus cream 1% with a decreasing trend over time, and one for Vehicle with relatively stable percentages. The x-axis represents time in days and the y-axis represents the percentage of body surface area affected with 95% confidence intervals.*
Carton1per30gm (Carton1per30gm)
Packaging label for Pimecrolimus Cream, 1% topical cream in a 30 g tube, manufactured by Glenmark Pharmaceuticals Ltd. and labeled for Glenmark Pharmaceuticals Inc., USA. The label includes usage instructions specifying topical use only and warns against ophthalmic use. Storage and puncturing instructions for the tube seal are provided. The label also includes manufacturer details, a barcode, and a caution for pharmacists regarding the enclosed Medication Guide.*
Structure (Image 01)
Chemical structure of Pimecrolimus, the active ingredient in the topical cream product. The structure shows the molecular arrangement with atoms and bonds characteristic of Pimecrolimus.*
Tube1per30gm (Tube1per30gm)
Pimecrolimus Cream, 1% topical, 30 g tube label from Glenmark Pharmaceuticals Inc., USA. Contains 10 mg/g pimecrolimus with inactive ingredients listed. Includes storage instructions and pharmacist notice about the medication guide. Manufactured by Glenmark Pharmaceuticals Ltd. in India, labeled for distribution by Glenmark Pharmaceuticals Inc., USA.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
